You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PF-06700841

Showing 1 - 25 of 1,083
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cicatricial Alopecia Trial in New York (PF-06700841, Placebo)

Recruiting
  • Cicatricial Alopecia
  • PF-06700841
  • Placebo
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 16, 2022

Healthy Participants Trial in Coral Gables, Miami (PF-06700841 IR, PF-06700841 MR1, PF-06700841 MR2)

Completed
  • Healthy Participants
  • PF-06700841 IR
  • +4 more
  • Coral Gables, Florida
  • +1 more
Mar 4, 2021

Acne Inversa Trial in Australia, Canada, United States (PF-06650833, PF-06700841, PF-06826647)

Completed
  • Acne Inversa
  • Birmingham, Alabama
  • +76 more
Jul 10, 2022

Healthy Female Volunteers Trial in Coral Gables, Miami (PF-06700841, Ethinyl estradiol (EE) and levonorgestrel (LN))

Completed
  • Healthy Female Volunteers
  • PF-06700841
  • Ethinyl estradiol (EE) and levonorgestrel (LN)
  • Coral Gables, Florida
  • +1 more
Nov 11, 2020

Active Non-segmental Vitiligo Trial in Worldwide (PF-06651600, , PF06700841)

Completed
Has Results
  • Active Non-segmental Vitiligo
  • Huntington Beach, California
  • +91 more
Mar 1, 2022

Crohn's Disease Trial in Worldwide (PF-06651600 Placebo, PF-06651600, Placebo PF-06700841)

Active, not recruiting
  • Crohn's Disease
  • PF-06651600 Placebo
  • +3 more
  • Dothan, Alabama
  • +187 more
Aug 17, 2022

Psoriatic Arthritis Trial in Worldwide (PF-06700841, Placebo)

Completed
Has Results
  • Psoriatic Arthritis
  • PF-06700841
  • Placebo
  • Maroochydore, Queensland, Australia
  • +47 more
Aug 2, 2021

Heathy Participants Trial in New Haven (PF-06700841, Itraconazole)

Completed
  • Heathy Participants
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Jan 28, 2020

Atopic Dermatitis Trial in Worldwide (PF-06700841, Vehicle (Placebo))

Completed
Has Results
  • Atopic Dermatitis
  • PF-06700841
  • Vehicle (Placebo)
  • Birmingham, Alabama
  • +75 more
Mar 3, 2021

Alopecia Areata Trial in Australia, Canada, United States (PF-06651600, PF-06700841, Placebo)

Completed
Has Results
  • Alopecia Areata
  • Birmingham, Alabama
  • +54 more
May 6, 2020

Healthy Trial in Osaka-shi (PF-06700841 cream, White petrolatum)

Completed
  • Healthy
  • PF-06700841 cream
  • White petrolatum
  • Osaka-shi, Osaka, Japan
    Medical Corporation Heishinkai OPHAC Hospital
May 23, 2019

Healthy Participants Trial in Brussels (PF-06700841 Immediate release tablets, PF-06700841 Modified release tablets)

Completed
  • Healthy Participants
  • PF-06700841 Immediate release tablets
  • PF-06700841 Modified release tablets
  • Brussels, Belgium
    Pfizer Clinical Research Unit
May 7, 2019

Healthy Male Subjects Trial in Groningen, Utrecht (Oral PF-06700841 containing 14C microtracer, Oral unlabeled PF-06700841, IV

Completed
  • Healthy Male Subjects
  • Oral PF-06700841 containing 14C microtracer
  • +2 more
  • Groningen, Netherlands
  • +1 more
Mar 5, 2019

Healthy Trial in Brussels (PF-06700841, Placebo, moxifloxacin)

Completed
  • Healthy
  • PF-06700841
  • +2 more
  • Brussels, Belgium
    Pfizer Clinical Research Unit
Feb 25, 2019

Dermatomyositis Trial in Orlando, Plantation (Brepocitinib, Placebo)

Recruiting
  • Dermatomyositis
  • Orlando, Florida
  • +1 more
Jun 24, 2022

Chronic Plaque Psoriasis Trial in Canada, Poland, United States (PF-06700841, Placebo)

Completed
Has Results
  • Chronic Plaque Psoriasis
  • PF-06700841
  • Placebo
  • Rogers, Arkansas
  • +43 more
Mar 28, 2019

Healthy Participants Trial (Single dose of PF-07220060 as first Tablet Formulation, Single dose of PF-07220060 as second Tablet

Not yet recruiting
  • Healthy Participants
  • Single dose of PF-07220060 as first Tablet Formulation
  • +3 more
  • (no location specified)
Jun 20, 2023

Atopic Dermatitis Trial in United States (PF-07275315, PF-07264660, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • Huntington Beach, California
  • +3 more
Aug 21, 2023

Healthy Trial (PF-07976016, Placebo, Midazolam)

Not yet recruiting
  • Healthy
  • (no location specified)
Oct 24, 2023

Hemiparesis;Poststroke/CVA Trial in Créteil (Eccentric training, Conventional therapy)

Recruiting
  • Hemiparesis;Poststroke/CVA
  • Eccentric training
  • Conventional therapy
  • Créteil, France
    Wael Maktouf
Nov 16, 2023

Healthy Trial in New Haven, Brussels (PF-07817883, Placebo, Midazolam)

Recruiting
  • Healthy
  • New Haven, Connecticut
  • +1 more
Dec 19, 2022

Pulmonary Arterial Hypertension Trial (PF-07868489, Placebo for PF-07868489)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • (no location specified)
Nov 14, 2023

Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Jun 7, 2023

Hemolysis During Pulsed-field and Radiofrequency Ablation

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • Pulsed-field ablation
  • Radiofrequency ablation
  • Prague, Czechia
    Cardiocenter, 3rd Medical School, Charles University and Univers
Oct 20, 2023

Healthy Trial in New Haven (PF-07328948, Placebo)

Recruiting
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 5, 2023